Concepedia

Li-Xiang Fu

LF

3

Publications

114

Citations

3

H-Index

2017

Active since

Affiliations

Guangxi Medical University(Current)

Guangxi University of Chinese Medicine

Liuzhou Maternal and Child Health Hospital

Li-Xiang Fu is an author at Guangxi Medical University specializing in liver physiology, medicine, and pharmacology.

Top concepts

MedicinePharmacologyLiver PhysiologyHepatocellular CarcinomaPathologyCancer ResearchHealthAllergyOncologyHepatology

Publications per year

2017–2020

3

Publications

3

The epigallocatechin gallate derivative Y6 inhibits human hepatocellular carcinoma by inhibiting angiogenesis in MAPK/ERK1/2 and PI3K/AKT/ HIF-1α/VEGF dependent pathways

Zhihong Liao, Hongqing Zhu, Yanyan Chen et al. · Journal of Ethnopharmacology · 2020 · 60 citations

Tumor Biology, Medicine, Liver Physiology +7

Effect of Y6, an epigallocatechin gallate derivative, on reversing doxorubicin drug resistance in human hepatocellular carcinoma cells

Yan Wen, Rui-Qiang Zhao, Yunkai Zhang et al. · Oncotarget · 2017 · 38 citations · Full text

Pharmaceutical Science, Doxorubicin Drug Resistance, Multidrug Resistance +20

The epigallocatechin gallate derivative Y6 reduces the cardiotoxicity and enhances the efficacy of daunorubicin against human hepatocellular carcinoma by inhibiting carbonyl reductase 1 expression

Huan Zhou, Li-Xiang Fu, Li Li et al. · Journal of Ethnopharmacology · 2020 · 16 citations

Hepatology, Human Hepatocellular Carcinoma, Medicine +9

Rows per page

1–3 of 3